Birchbox Assets Purchased from FemTec Health by Retention Brands

HOUSTON, May 12, 2023 /PRNewswire/ — Today, FemTec Health, Inc. announced the purchase of its Birchbox assets, effective April 12, 2023, by Retention Brands. Early this year as part of its strategic tightening around core healthcare businesses, FemTec Health engaged a national financial consulting firm to advise and explore possibilities for the sale of some of … Read more

LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate

SHANGHAI, May 12, 2023 /PRNewswire/ — LaNova Medicines Ltd. (“LaNova Medicines”) announced today it has entered into an exclusive license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), for LM-305, a pre-clinical stage antibody drug conjugate (ADC) targeting G protein-coupled receptor, class C, group 5, member D (GPRC5D). Under the terms of the licensing agreement, AstraZeneca will be … Read more

Child Care Aware® of America Celebrates Provider Appreciation Day®

Organization recognizes and celebrates efforts of child care providers   ARLINGTON, Va., May 12, 2023 /PRNewswire/ — Child Care Aware® of America (CCAoA) today celebrates Provider Appreciation Day® alongside states and communities across the country. Provider Appreciation Day is celebrated the Friday before Mother’s Day every year to recognize child care providers, teachers and other … Read more

Astellas’ VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause

 VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause TOKYO, May 12, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the U.S. Food and Drug Administration (FDA) has approved VEOZAHTM (fezolinetant) 45 mg once daily for … Read more

FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause

SILVER SPRING, Md., May 12, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. Veozah is the first neurokinin 3 (NK3) receptor antagonist approved by the FDA to treat moderate to severe hot flashes … Read more

Increasing Demand from End-use Industries Post COVID-19 Pandemic Bolsters Growth

DUBLIN, May 12, 2023 /PRNewswire/ — The “Industrial Cleaning Chemicals Market by Ingredient (Surfactants, Solvents, Chelating Agents), Product (General & Medical Cleaning), Application (Manufacturing & Commercial Offices, Healthcare, Retail & Food Service), and Region – Global Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The industrial cleaning chemicals market is projected to grow … Read more

Ergebnisse der klinischen Phase-I-Studie mit dem bifunktionalen PD-1/CTLA-4-Antikörper Iparomlimab/Tuvonralimab von Qilu Pharma wurden online im Journal of Hematology & Oncology veröffentlicht USA – Deutsch APAC – English USA – English USA – español

JINAN, China, 12. Mai 2023 /PRNewswire/ — Am 8. Mai 2023 veröffentliche das Journal of Hematology & Oncology (JHO, 2022 Impact Factor von 23.168) die Ergebnisse der klinischen Phase-I-Studie des bifunktionalen Immuntherapie-Antikörpers QL1706 von Qilu Pharma (J Hematol Oncol 8. Mai 2023;16(1):50). Diese Studie ist die erste große klinische Phase-I-Studie mit QL1706 am Menschen und … Read more

Sector to Reach $63.06 Billion at a 6.8% CAGR

DUBLIN, May 12, 2023 /PRNewswire/ — The “Global Medical Biomimetics Market Report and Forecast 2023-2031” report has been added to  ResearchAndMarkets.com’s offering. The value of the global medical biomimetics market was USD 34.73 billion in 2022, driven by the increasing demand for innovative medical products and technologies across the globe. The market value is anticipated to … Read more

Mitgo invests in mobile meditation app, Practico

CHICAGO, May 12, 2023 /PRNewswire/ — IT company Mitgo announced an investment into the mindfulness, meditation, and sleep quality mobile app, Practico. The US version, “Urso”, is expected to roll out by the end of Q2, 2023, supported by Mitgo’s Chicago office. The meditation and mindfulness market is booming, with revenues forecasted to reach $17.5b USD … Read more

Health Insurers No Longer Required to Cover COVID-19 Tests

End of COVID-19 Public Health Emergency Changes Insurance Coverage Rules TRUMBULL, Conn., May 12, 2023 /PRNewswire/ — Effective May 12, 2023, public and private health insurers are no longer required to cover COVID-19 diagnostic testing (including over-the-counter tests) at no cost to consumers, according to a blog post from the United States Department of Labor. … Read more